Pfizer VOR50 (Vfend 50 mg)
Generic Name: voriconazole
Pill imprint Pfizer VOR50 has been identified as Vfend 50 mg.
Vfend is used in the treatment of aspergillosis, invasive; cutaneous fungal infection; candidemia; coccidioidomycosis, meningitis; blastomycosis (and more), and belongs to the drug class azole antifungals. There is positive evidence of human fetal risk during pregnancy. Vfend 50 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- voriconazole
- Imprint:
- Pfizer VOR50
- Strength:
- 50 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Azole antifungals
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Pfizer U.S. Pharmaceuticals Group
- National Drug Code (NDC):
- 00049-3170
- Inactive Ingredients:
- lactose monohydrate
croscarmellose sodium
povidone
magnesium stearate
hypromelloses
titanium dioxide
triacetin
More about Vfend (voriconazole)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
